The Latest Breaking News from FDA

The National Vaccine Institute (NVI) plans to use locally developed Covid-19 vaccines as booster shots when they are completed and approved by the Food and Drug Administration (FDA).

As the Fed’s aggressive monetary policy resulted in slightly cooled inflation last month, investors are hopeful of smaller rate hikes ahead. However, since a recession is expected to hit the economy next year, we think fundamentally sound stocks Pfizer (PFE), Flowers Foods (FLO), and Xperi (XPER), which are rated Strong…

Regulators are beginning to smile on the sci-fi project of creating real meat products without the typical death and environmental destruction.

A new group of Jamaican resorts is promoting tourism that offers mystical experiences and stress relief through "magic mushrooms," as the Caribbean nation seeks to develop a niche industry in natural psychedelics.

Hemgenix frees patients from repeated treatments but initial cost makes it most expensive medicine in the world

Among the more remarkable legacies of the COVID-19 pandemic is how quickly federal regulators, the health care industry and consumers moved to make at-home testing a reliable tool for managing a public health crisis.

U.S. health regulators have approved the first gene therapy for hemophilia, a blood-clotting disorder with few treatment options

After years of setbacks, dementia researchers are getting excited about a new antibody drug called lecanemab. No one expects it to stop cognitive decline, but even slowing it would be a breakthrough

November is Lung Cancer Awareness month. Lung cancer is the most common cancer worldwide, with more than 2.1 million cases, according to the American Lung Association.

Conservative Christian group takes aim at abortion drug that is also used to treat miscarriages

AUSTIN, Texas — Abortion opponents on Friday asked a federal court to yank federal approval of a pill used to end pregnancies.